Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BEIJING, Feb. 14, 2018 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD), China's largest retailer, today announced that it plans to release its unaudited fourth quarter and full year 2017 financial...
-
BEIJING, Feb. 14, 2018 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ:JD), China’s largest retailer, today announced that it has entered into definitive agreements for the financing for its logistics...
-
CAMBRIDGE, Mass., and BEIJING, China, Feb. 09, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
-
MELBOURNE, Australia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- E-commerce giant JD.com (Nasdaq:JD), China’s largest retailer, has announced the opening of a local office in Australia as it accelerates...
-
SHANGHAI, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du,...
-
CAMBRIDGE, Mass. and BEIJING, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
-
BEIJING, China, and CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
-
CAMBRIDGE, Mass. and BEIJING, China, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
-
VANCOUVER, British Columbia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- China Gold International Resources Corp. Ltd. (TSX:CGG) (HKEx:2099) (“China Gold International Resources” or the “Company”) is ...
-
CAMBRIDGE, Mass. and BEIJING, China, Jan. 31, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...